CN110156467A - 一种活性高分子理疗材料 - Google Patents

一种活性高分子理疗材料 Download PDF

Info

Publication number
CN110156467A
CN110156467A CN201910551783.5A CN201910551783A CN110156467A CN 110156467 A CN110156467 A CN 110156467A CN 201910551783 A CN201910551783 A CN 201910551783A CN 110156467 A CN110156467 A CN 110156467A
Authority
CN
China
Prior art keywords
parts
powder
physical therapy
therapy material
jade
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910551783.5A
Other languages
English (en)
Inventor
傅加良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910551783.5A priority Critical patent/CN110156467A/zh
Publication of CN110156467A publication Critical patent/CN110156467A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/515—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics
    • C04B35/52—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on non-oxide ceramics based on carbon, e.g. graphite
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/62605—Treating the starting powders individually or as mixtures
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/327—Iron group oxides, their mixed metal oxides, or oxide-forming salts thereof
    • C04B2235/3272—Iron oxides or oxide forming salts thereof, e.g. hematite, magnetite
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3427—Silicates other than clay, e.g. water glass
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C04B2235/6562—Heating rate
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C04B2235/6567—Treatment time
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/658—Atmosphere during thermal treatment
    • C04B2235/6581—Total pressure below 1 atmosphere, e.g. vacuum

Abstract

本发明提供一种活性高分子理疗材料，包括：芦荟萃取物、玉石粉、六环石粉、海藻土、薰衣草、迷迭香、纤维素、沉香木、麦饭石、重钙粉、淀粉醚、胶粉、贝壳粉、檀香粉末、红豆杉叶、三七粉、南黄玛瑙粉末、墨玉粉末、磁石粉末，其质量配比为：芦荟萃取物1‑5份、玉石粉1‑5份、六环石粉1‑5份、海藻土1‑5份、薰衣草1‑5份、迷迭香0.1‑1份、纤维素0.1‑1份、沉香木0.1‑1份、麦饭石0.1‑1份、重钙粉1‑5份、淀粉醚1‑5份、胶粉1‑5份、贝壳粉0.1‑1份、檀香粉末0.1‑1份、红豆杉叶0.1‑1份、三七粉0.1‑1份、南黄玛瑙粉末1‑5份、墨玉粉末1‑5份、磁石粉末1‑5份。本发明可以促进脾脏、骨骼、淋巴结和胸腺免疫器官的发育，增强免疫细胞的活性，提高机体对抗细菌和病毒的能力。

Description

一种活性高分子理疗材料
技术领域
本发明涉及新型材料技术领域，具体为一种活性高分子理疗材料。
背景技术
理疗是利用人工或自然界物理因素作用于人体，使之产生有利的反应，达到预防和治疗疾病目的的方法，是康复治疗的重要内容。理疗的治疗的原理是：物理因素通过对局部的直接作用，和神经、体液的间接作用引起人体反应，调整血液循环，改善营养代谢，提高免疫功能，调节神经系统功能，促进组织修复，因而消除致病因素，改善病理过程，达到治病目的。自然界中存在一些具有治疗疾病作用的材料，研究出一种具有理疗作用的材料，利用这些特殊的材料中所蕴含的能量，唤醒现代人疲乏的身体，激活全身的淋巴与血液，净化肝肾等脏器，排除多余的毒素，能全面增强人的免疫能力，在理疗领域具有重要的意义。
发明内容
本发明所解决的技术问题在于提供一种活性高分子理疗材料，以解决上述背景技术中提出的问题。
本发明所解决的技术问题采用以下技术方案来实现：一种活性高分子理疗材料，包括：芦荟萃取物、玉石粉、六环石粉、海藻土、薰衣草、迷迭香、纤维素、沉香木、麦饭石、重钙粉、淀粉醚、胶粉、贝壳粉、檀香粉末、红豆杉叶、三七粉、南黄玛瑙粉末、墨玉粉末、磁石粉末，其质量配比为：芦荟萃取物1-5份、玉石粉1-5份、六环石粉1-5份、海藻土1-5份、薰衣草1-5份、迷迭香0.1-1份、纤维素0.1-1份、沉香木0.1-1份、麦饭石0.1-1份、重钙粉1-5份、淀粉醚1-5份、胶粉1-5份、贝壳粉0.1-1份、檀香粉末0.1-1份、红豆杉叶0.1-1份、三七粉0.1-1份、南黄玛瑙粉末1-5份、墨玉粉末1-5份、磁石粉末1-5份。
所述理疗材料其质量配比为：芦荟萃取物1份、玉石粉1份、六环石粉1份、海藻土1份、薰衣草1份、迷迭香0.1份、纤维素0.1份、沉香木0.1份、麦饭石0.1份、重钙粉1份、淀粉醚1份、胶粉1份、贝壳粉0.1份、檀香粉末0.1份、红豆杉叶0.1份、三七粉0.1份、南黄玛瑙粉末1份、墨玉粉末1份、磁石粉末1份。
所述理疗材料其质量配比为：芦荟萃取物2.3份、玉石粉3.5份、六环石粉2.3份、海藻土1.3份、薰衣草2份、迷迭香0.5份、纤维素0.2份、沉香木0.15份、麦饭石0.14份、重钙粉3.4份、淀粉醚4.1份、胶粉3份、贝壳粉0.35份、檀香粉末0.18份、红豆杉叶0.25份、三七粉0.23份、南黄玛瑙粉末3.2份、墨玉粉末2.1份、磁石粉末1.24份。
所述理疗材料其质量配比为：芦荟萃取物5份、玉石粉5份、六环石粉5份、海藻土5份、薰衣草5份、迷迭香1份、纤维素1份、沉香木1份、麦饭石1份、重钙粉5份、淀粉醚5份、胶粉5份、贝壳粉1份、檀香粉末1份、红豆杉叶1份、三七粉1份、南黄玛瑙粉末5份、墨玉粉末5份、磁石粉末5份。
一种活性高分子理疗材料制备方法，包括以下步骤：
步骤1.将理疗材料成分粉碎至粒度在200目以下，获得理疗材料成分粉；
步骤2.将理疗材料成分粉放入行星式球磨机内球磨4小时；所述行星式球磨机球磨时子氮气的气氛下进行球磨，磨球材质为不锈钢，球料比例为8：1，转速为200r*min-1；
步骤3.利用压力试验机进行压片，压力为500MPa，保压3分钟；之后在真空条件下利用真空炉进行烧结，烧结结束后，随炉冷却至室温得到活性高分子理疗材料；真空炉烧结参数为真空度为10-2～10-1Pa，升温速度为5～15℃/min，烧结温度为100～1000℃，压力为20～35MPa，保温时间5～10min。
与现有技术相比，本发明的有益效果是：本发明可以促进脾脏、骨骼、淋巴结和胸腺免疫器官的发育，增强免疫细胞的活性，提高机体对抗细菌和病毒的能力。
具体实施方式
为了使本发明的实现技术手段、创作特征、达成目的与功效易于明白了解，下面结合具体实施例，进一步阐述本发明，在本发明的描述中，需要说明的是，除非另有明确的规定和限定，术语“安装”、“连”、“连接”应做广义理解，例如，可以是固定连接，也可以是可拆卸连接，或一体地连接可以是机械连接，也可以是电连接；可以是直接相连，也可以通过中间媒介间接相连，可以两个元件内部的连通。
实施例1
一种活性高分子理疗材料制备方法，包括以下步骤：
步骤1.将芦荟萃取物1份、玉石粉1份、六环石粉1份、海藻土1份、薰衣草1份、迷迭香0.1份、纤维素0.1份、沉香木0.1份、麦饭石0.1份、重钙粉1份、淀粉醚1份、胶粉1份、贝壳粉0.1份、檀香粉末0.1份、红豆杉叶0.1份、三七粉0.1份、南黄玛瑙粉末1份、墨玉粉末1份、磁石粉末1份粉碎至粒度在200目以下，获得理疗材料成分粉；
步骤2.将理疗材料成分粉放入行星式球磨机内球磨4小时；所述行星式球磨机球磨时子氮气的气氛下进行球磨，磨球材质为不锈钢，球料比例为8：1，转速为200r*min-1；
步骤3.利用压力试验机进行压片，压力为500MPa，保压3分钟；之后在真空条件下利用真空炉进行烧结，烧结结束后，随炉冷却至室温得到活性高分子理疗材料；真空炉烧结参数为真空度为10-2～10-1Pa，升温速度为5～15℃/min，烧结温度为100～1000℃，压力为20～35MPa，保温时间5～10min。
实施例2
一种活性高分子理疗材料制备方法，包括以下步骤：
步骤1.将芦荟萃取物2.3份、玉石粉3.5份、六环石粉2.3份、海藻土1.3份、薰衣草2份、迷迭香0.5份、纤维素0.2份、沉香木0.15份、麦饭石0.14份、重钙粉3.4份、淀粉醚4.1份、胶粉3份、贝壳粉0.35份、檀香粉末0.18份、红豆杉叶0.25份、三七粉0.23份、南黄玛瑙粉末3.2份、墨玉粉末2.1份、磁石粉末1.24份粉碎至粒度在200目以下，获得理疗材料成分粉；
步骤2.将理疗材料成分粉放入行星式球磨机内球磨4小时；所述行星式球磨机球磨时子氮气的气氛下进行球磨，磨球材质为不锈钢，球料比例为8：1，转速为200r*min-1；
步骤3.利用压力试验机进行压片，压力为500MPa，保压3分钟；之后在真空条件下利用真空炉进行烧结，烧结结束后，随炉冷却至室温得到活性高分子理疗材料；真空炉烧结参数为真空度为10-2～10-1Pa，升温速度为5～15℃/min，烧结温度为100～1000℃，压力为20～35MPa，保温时间5～10min。
实施例3
一种活性高分子理疗材料制备方法，包括以下步骤：
步骤1.将芦荟萃取物5份、玉石粉5份、六环石粉5份、海藻土5份、薰衣草5份、迷迭香1份、纤维素1份、沉香木1份、麦饭石1份、重钙粉5份、淀粉醚5份、胶粉5份、贝壳粉1份、檀香粉末1份、红豆杉叶1份、三七粉1份、南黄玛瑙粉末5份、墨玉粉末5份、磁石粉末5份粉碎至粒度在200目以下，获得理疗材料成分粉；
步骤2.将理疗材料成分粉放入行星式球磨机内球磨4小时；所述行星式球磨机球磨时子氮气的气氛下进行球磨，磨球材质为不锈钢，球料比例为8：1，转速为200r*min-1；
步骤3.利用压力试验机进行压片，压力为500MPa，保压3分钟；之后在真空条件下利用真空炉进行烧结，烧结结束后，随炉冷却至室温得到活性高分子理疗材料；真空炉烧结参数为真空度为10-2～10-1Pa，升温速度为5～15℃/min，烧结温度为100～1000℃，压力为20～35MPa，保温时间5～10min。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明精神和范围的前提下，本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明范围内。本发明的要求保护范围由所附的权利要求书及其等效物界定。

Claims (5)

1.一种活性高分子理疗材料，其特征在于：包括：芦荟萃取物、玉石粉、六环石粉、海藻土、薰衣草、迷迭香、纤维素、沉香木、麦饭石、重钙粉、淀粉醚、胶粉、贝壳粉、檀香粉末、红豆杉叶、三七粉、南黄玛瑙粉末、墨玉粉末、磁石粉末，其质量配比为：芦荟萃取物1-5份、玉石粉1-5份、六环石粉1-5份、海藻土1-5份、薰衣草1-5份、迷迭香0.1-1份、纤维素0.1-1份、沉香木0.1-1份、麦饭石0.1-1份、重钙粉1-5份、淀粉醚1-5份、胶粉1-5份、贝壳粉0.1-1份、檀香粉末0.1-1份、红豆杉叶0.1-1份、三七粉0.1-1份、南黄玛瑙粉末1-5份、墨玉粉末1-5份、磁石粉末1-5份。
2.根据权利要求1所述的一种活性高分子理疗材料，其特征在于：所述理疗材料其质量配比为：芦荟萃取物1份、玉石粉1份、六环石粉1份、海藻土1份、薰衣草1份、迷迭香0.1份、纤维素0.1份、沉香木0.1份、麦饭石0.1份、重钙粉1份、淀粉醚1份、胶粉1份、贝壳粉0.1份、檀香粉末0.1份、红豆杉叶0.1份、三七粉0.1份、南黄玛瑙粉末1份、墨玉粉末1份、磁石粉末1份。
3.根据权利要求1所述的一种活性高分子理疗材料，其特征在于：所述理疗材料其质量配比为：芦荟萃取物2.3份、玉石粉3.5份、六环石粉2.3份、海藻土1.3份、薰衣草2份、迷迭香0.5份、纤维素0.2份、沉香木0.15份、麦饭石0.14份、重钙粉3.4份、淀粉醚4.1份、胶粉3份、贝壳粉0.35份、檀香粉末0.18份、红豆杉叶0.25份、三七粉0.23份、南黄玛瑙粉末3.2份、墨玉粉末2.1份、磁石粉末1.24份。
4.根据权利要求1所述的一种活性高分子理疗材料，其特征在于：所述理疗材料其质量配比为：芦荟萃取物5份、玉石粉5份、六环石粉5份、海藻土5份、薰衣草5份、迷迭香1份、纤维素1份、沉香木1份、麦饭石1份、重钙粉5份、淀粉醚5份、胶粉5份、贝壳粉1份、檀香粉末1份、红豆杉叶1份、三七粉1份、南黄玛瑙粉末5份、墨玉粉末5份、磁石粉末5份。
5.一种活性高分子理疗材料制备方法，其特征在于：包括以下步骤：
步骤1.将理疗材料成分粉碎至粒度在200目以下，获得理疗材料成分粉；
步骤2.将理疗材料成分粉放入行星式球磨机内球磨4小时；所述行星式球磨机球磨时子氮气的气氛下进行球磨，磨球材质为不锈钢，球料比例为8：1，转速为200r*min-1；
步骤3.利用压力试验机进行压片，压力为500MPa，保压3分钟；之后在真空条件下利用真空炉进行烧结，烧结结束后，随炉冷却至室温得到活性高分子理疗材料；真空炉烧结参数为真空度为10-2～10-1Pa，升温速度为5～15℃/min，烧结温度为100～1000℃，压力为20～35MPa，保温时间5～10min。
CN201910551783.5A 2019-06-25 2019-06-25 一种活性高分子理疗材料 Pending CN110156467A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910551783.5A CN110156467A (zh) 2019-06-25 2019-06-25 一种活性高分子理疗材料

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910551783.5A CN110156467A (zh) 2019-06-25 2019-06-25 一种活性高分子理疗材料

Publications (1)

Publication Number Publication Date
CN110156467A true CN110156467A (zh) 2019-08-23

Family

ID=67625575

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910551783.5A Pending CN110156467A (zh) 2019-06-25 2019-06-25 一种活性高分子理疗材料

Country Status (1)

Country Link
CN (1) CN110156467A (zh)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274457A (zh) * 2011-07-25 2011-12-14 郑荣杰 一种用于刮痧、按摩的理疗强化喷剂
CN105347723A (zh) * 2014-08-18 2016-02-24 白山市土纳硅藻新型材料有限公司 一种可反复使用的硅藻泥
CN106177353A (zh) * 2016-07-28 2016-12-07 隋丽梅 一种肛肠疾病消毒护理液及其制备方法
CN106309490A (zh) * 2016-10-21 2017-01-11 青岛首创嘉业工贸有限公司 一种活性理疗环及其制备方法
CN107352989A (zh) * 2017-07-12 2017-11-17 广东康世泰新材料科技股份有限公司 一种能修复人体受损细胞的陶瓷制品及其制备方法
CN107753832A (zh) * 2017-11-18 2018-03-06 明光市海港凹坭矿业有限公司 一种保健理疗功能的托玛琳颗粒及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274457A (zh) * 2011-07-25 2011-12-14 郑荣杰 一种用于刮痧、按摩的理疗强化喷剂
CN105347723A (zh) * 2014-08-18 2016-02-24 白山市土纳硅藻新型材料有限公司 一种可反复使用的硅藻泥
CN106177353A (zh) * 2016-07-28 2016-12-07 隋丽梅 一种肛肠疾病消毒护理液及其制备方法
CN106309490A (zh) * 2016-10-21 2017-01-11 青岛首创嘉业工贸有限公司 一种活性理疗环及其制备方法
CN107352989A (zh) * 2017-07-12 2017-11-17 广东康世泰新材料科技股份有限公司 一种能修复人体受损细胞的陶瓷制品及其制备方法
CN107753832A (zh) * 2017-11-18 2018-03-06 明光市海港凹坭矿业有限公司 一种保健理疗功能的托玛琳颗粒及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
尹晓萍 等: "《医学理论与实践》", 30 April 2019 *

Similar Documents

Publication Publication Date Title
CN108618151B (zh) 一种保持菌种活性的益生菌微胶囊及其制备方法
CN106800407A (zh) 一种新型复合矿石
CN106798755B (zh) 一种具有调理乳腺增生功能的益生菌组合物及其应用
CN103283884A (zh) 金花灵芝茶保健品的制作工艺
CN105030950B (zh) 防治高血脂的微生态制剂及其制备方法和应用
CN106234709A (zh) 灵芝茶及其制备方法
CN105475578A (zh) 一种灵芝咖啡茶及其制备方法
CN103999988B (zh) 一种具有保健养生功能的鹿角灵芝紫苏硒茶
CN110156467A (zh) 一种活性高分子理疗材料
CN104305170A (zh) 一种用于放疗术后调养的中药药膳配方及其制备方法
CN106822597A (zh) 一种新型发酵中药及其制备方法和用途
CN105613831A (zh) 一种灵芝红茶及其制备方法
CN102727645A (zh) 一种水产用发酵中药及其制备方法
CN105343916A (zh) 一种佛手茶檀香及其制备方法
CN105749099B (zh) 一种治疗胃癌的益生菌发酵中药组合物及其制备方法和应用
CN100398012C (zh) 一种抗氧化和改善睡眠的保健食品
CN105596930A (zh) 一种气管病的发酵微生物中药制剂及其制备方法与应用
CN104491448A (zh) 一种治疗风热外袭型三叉神经痛的中药组合物
CN106581201A (zh) 治疗心热风邪的药物
CN109700931A (zh) 一种用于慢性阻塞性肺疾病并发间皮瘤的药物及其制备方法
CN108014302A (zh) 一种具有抗宫颈癌作用的发酵组合物及其制备方法
CN106212826A (zh) 花茶及其制备方法
CN107376107A (zh) 用于抗衰老的热疗床及其使用方法
CN106074775A (zh) 一种涩肠止泻中药组合物
CN105983073A (zh) 一种治疗过敏性皮炎的中药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190823

RJ01 Rejection of invention patent application after publication